Influenza Antiviral Drugs Market contains market size and forecasts of Influenza Antiviral Drugs in Global, including the following market information:
- Global Influenza Antiviral Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Influenza Antiviral Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
- The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
- Oseltamivir Segment to Reach $ Million by 2028, with a % CAGR in next six years.
- The global key manufacturers of Influenza Antiviral Drugs include GSK, Boehringer Ingelheim, Merck, Novartis, Beximco Pharmaceuticals, Pfizer, Roche, Johnson & Johnson and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
- We surveyed the Influenza Antiviral Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Influenza Antiviral Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Influenza Antiviral Drugs Market Segment Percentages, by Type, 2021 (%)
- Oseltamivir
- Zanamivir
- Peramivir
- Adamantanes
- Others
Global Influenza Antiviral Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Influenza Antiviral Drugs Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Pharmacies
- Others
Global Influenza Antiviral Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Influenza Antiviral Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Influenza Antiviral Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Influenza Antiviral Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- GSK
- Boehringer Ingelheim
- Merck
- Novartis
- Beximco Pharmaceuticals
- Pfizer
- Roche
- Johnson & Johnson
- Sanofi
- Cipla Limited
- Natco Pharma
- Seqirus
- Adamas Pharmaceuticals, Inc.
- Teva Pharmaceuticals
- Daiichi Sankyo Company
Industry Market Size
